Publicador de contenidos

Back to La investigadora de la Universidad de Navarra Elena Puerta, becada por la fundación Ramón Areces

Elena Puerta, researcher at the University of Navarra, awarded a grant by the Ramón Areces Foundation.

He will stay one year at high school Karolinska in Stockholm to study the role of cholesterol metabolism in Alzheimer's disease.

26/08/10 10:25
Image description
Elena Puerta, researcher at department of Pharmacology. PHOTO: Manuel Castells

research Elena Puerta Ruiz de Azúa, a researcher at the University of Navarra, has obtained a scholarship grant from the Ramón Areces Foundation to carry out a postdoctoral fellowship at high school Karolinska in Stockholm (Sweden).

Elena Puerta, from department of Pharmacology at the academic center, will begin her stay on October 1. For one year she will study the role of cholesterol metabolism in the etiology of Alzheimer's disease, since, as she explains, "several in vivo and in vitro genetic programs of study have highlighted its importance in modulating the risk, origin and evolution of this disease".

The research will make it possible to assess how changes in cholesterol metabolism can influence the generation of Aß, one of the main molecular markers in the brains of patients with this pathology. "This could lead in the future to propose the modulation of neuronal cholesterol levels as a potential therapeutic for the treatment of Alzheimer's disease," he says.

 

 

22 postdoctoral grants

Elena Puerta, a native of Hondarribia (Guipuzcoa) and first national award end of degree program of Pharmacy, has obtained one of the 22 postdoctoral grants that the Ramón Areces Foundation has awarded to carry out programs of study on Nature Sciences in universities and centers of research abroad.

The high school Karolinska, where he will carry out his stay, is one of the most important academic centers of research in the world and has a great historical tradition being in charge of nominating the award Nobel Prize in Medicine annually. In the field of Neuroscience and specifically Alzheimer's disease, it has been rated several times as the best in Europe and one of the best in the world.

BUSCADOR NOTICIAS

SEARCH ENGINE NEWS

From

To